Previous Close | 4.4700 |
Open | 4.4200 |
Bid | 0.0000 x 4000 |
Ask | 0.0000 x 4000 |
Day's Range | 4.2700 - 4.5100 |
52 Week Range | 2.5200 - 12.5550 |
Volume | |
Avg. Volume | 2,562,108 |
Market Cap | 1.123B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7210 |
Earnings Date | Mar 22, 2022 - Mar 28, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.98 |
The catalyst that sent the telehealth software company higher was bullish commentary courtesy of a Wall Street analyst. Piper Sandler analyst Sean Wieland raised his price target on American Well (also called Amwell) to $6, up from its previous level of $5. The analyst cited numerous client wins, including the recent signing of CVS Health (NYSE: CVS), which he sees as "marquee reference customers."
Among the hottest stocks last month was Amwell (NYSE: AMWL). It was shortly after the company reported earnings last month that Amwell's stock started to gain momentum. For the first three months of 2022, Amwell posted sales of $64.2 million which rose 12% year over year.
BOSTON, June 08, 2022--Amwell appoints Dr. Carrie Nelson to the role of Chief Medical Officer.